Pekin Hardy Strauss’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Pekin Hardy Strauss’s Portfolio IDXG Stock Details IDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,996	Closed	-$285K	–	174
2015 Q2	$285K	Sell	1,996 -830	-29%	-$115K	0.06%	129
2015 Q1	$382K	Sell	2,826 -197	-7%	-$32.2K	0.07%	101
2014 Q4	$541K	Sell	3,023 -3,341	-52%	-$594K	0.08%	145
2014 Q3	$1.53M	Sell	6,364 -1	-0%	-$334	0.26%	53
2014 Q2	$2.79M	Hold	6,365	–	–	0.44%	39
2014 Q1	$2.92M	Sell	6,365 -63	-1%	-$32.7K	0.47%	37
2013 Q4	$3.09M	Hold	6,428	–	–	0.48%	35
2013 Q3	$3.1M	Hold	6,428	–	–	0.49%	34
2013 Q2	$3.02M	Buy	+6,428	New	+$2.92M	0.51%	33

Other funds holding IDXG

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

SKK

Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Pekin Hardy Strauss's IDXG Position: Q3 2015 in Review

Pekin Hardy Strauss sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q3 2015, closing a stake of 1,996 shares — an estimated $285K sold.

Pekin Hardy Strauss first reported a position in IDXG in Q2 2013 and held it in 9 quarters. The position peaked at $3.1M in Q3 2013. 22 funds tracked by Wall St. Rank hold IDXG as of Q3 2015.

Pekin Hardy Strauss reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
Pekin Hardy Strauss sold 1,996 Interpace Biosciences, Inc. Common Stock shares in Q3 2015, an estimated $285K.
Pekin Hardy Strauss first reported a position in Interpace Biosciences, Inc. Common Stock in Q2 2013 and held it in 9 quarters.
Pekin Hardy Strauss's Interpace Biosciences, Inc. Common Stock position peaked at $3.1M in Q3 2013.
22 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q3 2015.

Based on Pekin Hardy Strauss's 13F filing for Q3 2015, filed 10 Nov 2015.